Loading...
Not a good buy right now. Price action is only mildly constructive and sits below the key pivot (1.198), Intellectia has no actionable buy signals today, and the latest quarter (2025/Q3) shows steep YoY declines in revenue, earnings, and EPS. With no option-market confirmation and no notable insider/hedge/congress accumulation signals, the risk/reward does not favor an impatient entry at $1.13.
Intellectia Proprietary Trading Signals:
Politicians / influential figures: No recent congress trading data available (last 90 days).
Trend/Setup: Mixed-to-slightly bullish but not a high-conviction breakout.
News sentiment: Positive/constructive.
Trading trends: Hedge funds neutral; insiders neutral (no negative pressure indicated).
and momentum is not strengthening (MACD contracting).
Latest quarter: 2025/Q3.
No analyst rating / price target change data provided, so the current Wall Street pro/con view cannot be verified from this dataset. Based on the available data only: pros are product/partner expansion in cannabis payments; cons are steep YoY financial declines and lack of strong technical/trading-signal confirmation.
